Given the observed upregulation of the NOS2/ARG1 axis both in vivo and in situ, we aimed to examine the relationship between NOS2 and ARG1 expression, tissue damage, and the subtypes of infiltrating immune cells during CRC progression. The gene discussed is NOS2; the disease is colorectal carcinoma.